NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-119-2025-0-US-02 Compositions of Bifunctional Inhibitors of Tetracycline Inactivating Enzymes and Methods of Use Thereof US ORD 19/072,517 Pending
NCI E-285-2016-2-JP-02 Glypican 2 As A Cancer Marker And Therapeutic Target JP DIV 2025-034156 Pending
NIAID E-087-2019-0-US-04 NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE US CON 19/069,538 Pending
NCI E-100-2018-0-US-05 3-O-SULFO-GALACTOSYLCERAMIDE ANALOGS AS ACTIVATORS OF TYPE II NKT CELLS AND USES THEREOF US DIV 19/069,431 Pending
NCI E-181-2017-0-CN-01 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS CN DIV 202510245856.3 Pending
NIBIB E-078-2024-0-PC-01 THERMO-SENSITIVE ANTI-FUNGAL HYDROGEL COMPOSITIONS AND METHODS OF USE PCT PCT PCT/US2025/017838 Pending
NIAID E-174-2023-0-US-03 Self-Assembling Nanoparticles US CON 19/067,426 Pending
NCI E-044-2022-0-CN-01 KINASE INHIBITORS CN National Stage 202380062947.2 Pending
NCI E-129-2022-0-CN-01 CD25-SPECIFIC ANTIBODIES AND USES THEREOF CN National Stage 202380063234.8 Pending
NIA E-151-2022-0-EP-01 HALOPHTHALIMIDE COMPOUNDS AND METHODS OF USE AGAINST TBI, INFLAMMATORY DISORDER, AUTOIMMUNE DISORDER, NEURODEGENERATIVE DISEASE OR VIRAL INFECTION EP National Stage 23762066.1 Pending
NIDDK E-138-2017-0-JP-01 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS JP DIV 2025-031851 Pending
NCI E-181-2017-0-KR-01 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS KR DIV 10-2025-7006999 Pending
CC E-050-2024-0-PCT-02 SYSTEMS AND METHODS FOR INTEGRATED IMAGING AND MULTI-VIEW AUGMENTED
REALITY FOR SURGICAL INTERVENTION 		PCT PCT PCT/US2025/017696 Pending
NIAID E-233-2023-0-PC-01 SINGLE-DOMAIN AND BISPECIFIC ANTIBODIES TO HIV-1 ENV AND THEIR USE PCT PCT PCT/US2025/017707 Pending
NCI E-169-2022-0-US-02 SINGLE DOMAIN ANTIBODIES TARGETING HPV E6/E7 ONCOGENIC PEPTIDE/MHC
COMPLEXES 		US National Stage 19/107,498 Pending
NIAID E-183-2022-0-US-02 NANOPARTICLE-DERIVED VACCINES AGAINST POXVIRUSES, AND METHODS FOR MAKING AND USING THE SAME US National Stage 19/107,331 Pending
NIDA E-133-2022-0-EP-01 SELECTIVE OPIOID RECEPTOR AGONISTS AND ANTAGONISTS EP National Stage 23758151.7 Pending
NIAID E-197-2023-1-CN-01 ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM5] CN National Stage 202380061883.4 Pending
NIAID E-197-2023-0-CN-01 ANTI-SARS-COV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF CN National Stage 202380061863.7 Pending
NEI E-293-2016-0-JP-10 TISSUE CLAMP AND IMPLANTATION METHOD JP DIV 2025-027718 Pending
NCI E-128-2022-1-PC-01 TREATMENT OF CARDIOVASCULAR DISEASE WITH TEM8 ANTIBODIES PCT PCT PCT/US2025/017061 Pending
NICHD E-182-2023-0-PC-01 DYNAMIC ASSESSMENT OF CELLULAR METABOLISM THROUGH OPTICAL IMAGING AND ARTIFICIAL INTELLIGENCE TECHNIQUES PCT PCT PCT/US2025/016781 Pending
NIAID E-240-2023-0-EP-02 VACCINES AGAINST CORONAVIRUSES EP National Stage 23768415.4 Pending
NIAID E-240-2023-0-JP-01 VACCINES AGAINST CORONAVIRUSES JP National Stage 2025-511847 Pending
NIAID E-240-2023-0-US-04 VACCINES AGAINST CORONAVIRUSES US National Stage 19/105,579 Pending
NHLBI E-017-2024-3-PC-01 SYSTEMS AND METHODS FOR INTRAMYOCARDIAL ABLATION (VINTAGE) PCT PCT COMB PCT/US2025/016665 Pending
NIAID E-240-2023-0-AU-01 VACCINES AGAINST CORONAVIRUSES AU National Stage 2023330867 Pending
NIAID E-240-2023-0-CA-01 VACCINES AGAINST CORONAVIRUSES CA National Stage 3265295 Pending
NCI E-084-2022-0-US-01 Preparation Of 3, 4-dihydroquinolin-2(1H)-one Compounds As Inhibitors Or Modulators Of Artemis Endonuclease For The Treatment Of Cancer US 63/759,935 Expired
NHLBI E-134-2022-0-US-02 SYSTEMS AND METHODS FOR ELECTROCARDIOGRAPHIC RADIAL DEPTH NAVIGATION OF INTRACARDIAC DEVICES US National Stage 19/104,170 Pending
NCI E-044-2022-0-IN-01 KINASE INHIBITORS IN National Stage 202547012577 Pending
NCI E-135-2019-0-JP-01 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 JP DIV 2025-020882 Pending
NCATS E-022-2018-0-JP-01 COMPOSITIONS AND METHODS FOR CELL CULTURE JP DIV 2025-020820 Pending
NCATS E-145-2024-0-US-01 RFXP1 AGONISTS US 63/757,235 Expired
NIA E-151-2022-0-US-02 HALOPHTHALIMIDE COMPOUNDS AND METHODS OF USE AGAINST TBI, INFLAMMATORY DISORDER, AUTOIMMUNE DISORDER, NEURODEGENERATIVE DISEASE OR VIRAL INFECTION US National Stage 19/102,830 Pending
NCI E-051-2024-0-PC-01 MONOCLONAL ANTIBODIES THAT BIND THE JUXTA-MEMBRANE REGION OF MESOTHELIN AND USES THEREOF (R04 antibody) PCT PCT PCT/US2025/014973 Pending
NHLBI E-134-2022-0-CN-01 SYSTEMS AND METHODS FOR ELECTROCARDIOGRAPHIC RADIAL DEPTH NAVIGATION OF INTRACARDIAC DEVICES CN National Stage 202380058215.6 Abandoned
NIDCD E-173-2022-0-EP-01 IMPEDING PLATINUM-BASED CHEMOTHERAPEUTIC INDUCED OTOTOXICITY USING A COLONY STIMULATING FACTOR 1 RECEPTOR INHIBITOR EP National Stage 23751479.9 Pending
NCI E-174-2022-0-US-02 Synergistic Interactions For Improved Cancer Treatment US National Stage 19/101,938 Pending
NIAID E-081-2013-4-KR-29 Prefusion RSV F Proteins And Their Use KR DIV 10-2025-7003905 Pending
NIDDK E-138-2017-0-HK-01 COMPOUNDS AND METHODS FOR TREATING BRAIN INJURY HK EP 42025102931.0 Pending
NCI E-044-2022-0-EP-01 KINASE INHIBITORS EP National Stage 23755549.5 Pending
NIAID E-177-2022-0-US-02 MONOCLONAL ANTIBODIES THAT BIND TO THE UNDERSIDE OF INFLUENZA VIRAL
NEURAMINIDASE 		US National Stage 19/100,498 Pending
NHGRI E-071-2024-0-PC-01 SYNTHETIC GBA1 GENES PCT PCT PCT/US2025/013849 Pending
NCATS E-204-2022-2-US-02 MULTI-CYCLIC IRAK1 AND IRAK4 INHIBITING COMPOUNDS AND USES THEREOF US National Stage 19/099,849 Pending
NCI E-212-2023-0-PC-01 PREDICTING DNA METHYLATION AND TUMOR TYPES FROM HISTOPATHOLOGY PCT PCT PCT/US2025/013654 Pending
NCI E-174-2022-0-EP-01 Synergistic Interactions For Improved Cancer Treatment EP National Stage 23768747.0 Pending
NIAID E-197-2023-1-IN-01 ANTI-SARS-COV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF IN National Stage 202517007580 Pending
NCI E-173-2024-0-US-01 TEM8 MONOCLONAL ANTIBODIES AND THEIR USE US 63/750,425 Expired
NIDA E-133-2022-0-US-02 SELECTIVE OPIOID RECEPTOR AGONISTS AND ANTAGONISTS US National Stage 19/099,189 Pending